Caxton Associates (New York)’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
Other funds holding ACA
RA
CII
Caxton Associates (New York)'s ACA Position: Q1 2022 in Review
Caxton Associates (New York) sold out of Arcosa (ACA) in Q1 2022, closing a stake of 9,095 shares — an estimated $479K sold.
Caxton Associates (New York) first reported a position in ACA in Q3 2021 and held it in 2 quarters. The position peaked at $1.16M in Q3 2021. 255 funds tracked by Wall St. Rank hold ACA as of Q1 2022.
- Caxton Associates (New York) reported no remaining Arcosa position as of Q1 2022 after selling out during the quarter.
- Caxton Associates (New York) sold 9,095 Arcosa shares in Q1 2022, an estimated $479K.
- Caxton Associates (New York) first reported a position in Arcosa in Q3 2021 and held it in 2 quarters.
- Caxton Associates (New York)'s Arcosa position peaked at $1.16M in Q3 2021.
- 255 funds tracked by Wall St. Rank held Arcosa as of Q1 2022.
Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.